Pharma Deals Review, Vol 2010, No 7 (2010)

Font Size:  Small  Medium  Large

Emergent BioSolutions Looks beyond Biodefence with Trubion Acquisition

Heather Cartwright

Abstract


Emergent BioSolutions, best known for its prophylactic anthrax vaccine BioThrax® (anthrax vaccine adsorbed), has acquired Trubion Pharmaceuticals in order to expand its pipeline beyond infectious diseases and into oncology and autoimmune diseases.



Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.